1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/78180
Registro completo de metadatos
Campo DCValorIdioma
dc.creatorChit Cheng Yeohpt_BR
dc.creatorNedal Dababpt_BR
dc.creatorElyse Rigbypt_BR
dc.creatorRitu Chhikarapt_BR
dc.creatorIolia Akaevpt_BR
dc.creatorRicardo Santiago Gomezpt_BR
dc.creatorFelipe Paiva Fonsecapt_BR
dc.creatorPeter Brennanpt_BR
dc.creatorSiavash Rahimipt_BR
dc.date.accessioned2024-11-21T19:39:50Z-
dc.date.available2024-11-21T19:39:50Z-
dc.date.issued2018-
dc.citation.volume47pt_BR
dc.citation.issue7pt_BR
dc.citation.spage691pt_BR
dc.citation.epage695pt_BR
dc.identifier.doihttps://doi.org/10.1111/jop.12741pt_BR
dc.identifier.issn1600-0714pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/78180-
dc.description.resumoThe role of the androgen receptor (AR) as an immunomarker for diagnosis of salivary gland duct carcinoma (SDC) is well known. Other non-squamous cell head and neck cancers (NSCC-HN), including a small subset of salivary gland cancers (SGCs), can also express AR. With the increase in effective and powerful new generation of anti-androgen agents and drugs administered orally, more targetable AR-driven NSCC-HN, such as subsets of SGCs, should be investigated for possible expression of AR. In this review, we focus on SGC subtypes, which could express AR and describe the main androgen deprivation therapy (ADT) strategies.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentFAO - DEPARTAMENTO DE CLÍNICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofJournal of Oral Pathology & Medicinept_BR
dc.rightsAcesso Abertopt_BR
dc.subjectAbirateronept_BR
dc.subjectandrogen receptorpt_BR
dc.subjectEnzalutamidept_BR
dc.subjectHead and neckpt_BR
dc.subjectimmunohistochemistrypt_BR
dc.subjectNon-squamous cell carcinomapt_BR
dc.subjectSalivary gland carcinomapt_BR
dc.subject.otherAbiraterone acetatept_BR
dc.subject.otherReceptors, androgenpt_BR
dc.subject.otherImmunohistochemistrypt_BR
dc.subject.otherCarcinoma, mucoepidermoidpt_BR
dc.subject.otherCarcinoma, adenoid cysticpt_BR
dc.subject.otherAdenocarcinomapt_BR
dc.subject.otherPrognosispt_BR
dc.subject.otherRadiotherapypt_BR
dc.subject.otherExcision repairpt_BR
dc.subject.otherAndrogen antagonistspt_BR
dc.subject.otherDrug therapypt_BR
dc.titleAndrogen receptor in salivary gland carcinoma: a review of an old marker as a possible new targetpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://onlinelibrary.wiley.com/doi/10.1111/jop.12741pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-6026-9843pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-9214-9301pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4351-8147pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-8770-8009pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6657-4547pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-4804-3264pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8282-1480pt_BR
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
archivo Descripción TamañoFormato 
Androgen receptor in salivary gland carcinoma A review of an old marker as a possible new target.pdf972.8 kBAdobe PDFVisualizar/Abrir
Mostrar registro simple del elemento Visualizar estadísticas


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.